Francois Peyron
Laboratoire de Parasitologie et Pathologie Exotique
Hôpital de Croix Rousse
France
Name/email consistency: high
- When are we going to celebrate the centenary of the discovery of efficient treatment for congenital toxoplasmosis? Peyron, F. Mem. Inst. Oswaldo Cruz (2009)
- Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Peyron, F., Lobry, J.R., Musset, K., Ferrandiz, J., Gomez-Marin, J.E., Petersen, E., Meroni, V., Rausher, B., Mercier, C., Picot, S., Cesbron-Delauw, M.F. Microbes Infect. (2006)
- Fitness of Toxoplasma gondii is not related to DHFR single-nucleotide polymorphism during congenital toxoplasmosis. Peyron, F., Eudes, N., de Monbrison, F., Wallon, M., Picot, S. Int. J. Parasitol. (2004)
- Congenital toxoplasmosis in twins: a report of fourteen consecutive cases and a comparison with published data. Peyron, F., Ateba, A.B., Wallon, M., Kodjikian, L., Binquet, C., Fleury, J., Garweg, J.G. Pediatr. Infect. Dis. J. (2003)
- Options for the pharmacotherapy of toxoplasmosis during pregnancy. Peyron, F., Wallon, M. Expert. Opin. Pharmacother (2001)